Top Biotechnology & Medical Research stocks in United States

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Market Cap
Price to Earnings
Dividend Yield
us flag iconVRTXVertex Pharmaceuticals$92.47bn27.69n/a
us flag iconREGNRegeneron Pharmaceuticals$90.84bn21.69n/a
us flag iconMRNAModerna$40.62bn39.47n/a
us flag iconSGENSeagen$39.10bnn/an/a
us flag iconIQVIqvia Holdings$38.25bn34.51n/a
us flag iconBNTXBioNTech SE$26.48bn5.89n/a
us flag iconALNYAlnylam Pharmaceuticals$21.96bnn/an/a
us flag iconICLRIcon$21.63bn36.58n/a
us flag iconEXASExact Sciences$13.66bnn/an/a
us flag iconNBIXNeurocrine Biosciences$11.21bn42.47n/a
us flag iconTECHBIO-TECHNE$11.18bn47.670.45%
us flag iconSRPTSarepta Therapeutics$11.11bnn/an/a
us flag iconLEGNLegend Biotech$10.81bnn/an/a
us flag iconCRLCharles River Laboratories International$10.69bn27.61n/a
us flag iconUTHRUnited Therapeutics$10.36bn12.32n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconQGENQiagen NV$9.15bn24.46n/a
us flag iconMEDPMedpace Holdings$7.82bn30.58n/a
us flag iconEXELExelixis$6.82bn42.62n/a
us flag iconKRTXKaruna Therapeutics$6.58bnn/an/a